What is Biohaven's common stock?

Biohaven (BHVN) reported common stock of 200M in Q1 2026.

How has Biohaven's common stock changed year-over-year?

Biohaven's common stock decreased by 0.0% year-over-year, from 200M to 200M.

What does common stock mean?

The par value of all common shares issued and outstanding, typically a nominal amount ($0.01 or $0.001 per share).

Biohaven BHVN Common Stock

Common Stock at other companies

Eli LillyLLY

$590M-0.4%

Xenon PharmaceuticalsXENE

$2.42B+65.8%

Rapport Therapeutics, Inc.RAPP

$48K+29.7%

Vir Biotechnology, Inc.VIR

300M0.0%

uniQureQURE

$3.73M+15.1%

Roivant SciencesROIV

$0—

Other financials

Income statement

See full

Operating income-$130.4M+41.1%

Net income-$130.5M+41.1%

EPS (diluted)-$0.88+59.4%

Balance sheet

See full

Cash & equivalents$277.1M+170%

Total debt$286.2M+706%

Total equity$129.5M-50.1%

Total assets$466.4M+1.6%

Cash flow

See full

Operating cash flow-$149.9M+9.2%

CapEx--100%

Free cash flow-$149.9M+9.5%

Valuation

See full

Market cap$2.23B-48.1%

Enterprise value$2.23B-46.3%

Returns & leverage

See full

Return on equity-333%+17.9pp

Debt / equity2.2×+2.1×

Current ratio7.4×+5.1×

Where this comes from

Reported directly by Biohaven in its filing.

Tagged under the XBRL concept us-gaap:CommonStockSharesAuthorized.

The official record: Biohaven’s 10-Q, filed May 4, 2026, on SEC EDGAR. View the filing →

Ask your AI about Biohaven's common stock.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI

Claude

Questions, answered.

What is Biohaven's common stock?: Biohaven (BHVN) reported common stock of 200M in Q1 2026.
How has Biohaven's common stock changed year-over-year?: Biohaven's common stock decreased by 0.0% year-over-year, from 200M to 200M.
What does common stock mean?: The par value of all common shares issued and outstanding, typically a nominal amount ($0.01 or $0.001 per share).